PHK
STOK icon

Point72 Hong Kong’s Stoke Therapeutics STOK Stock Holding History

Point72 Hong Kong’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,636
Closed -$21K – 1482
2022
Q3 		$21K Sell
1,636
-202
-11% -$3.22K ﹤0.01% 1611
2022
Q2 		$24K Buy
1,838
+548
+42% +$8.32K ﹤0.01% 1524
2022
Q1 		$27K Buy
+1,290
New +$25.8K ﹤0.01% 1480
2021
Q3 		– Sell
-1,363
Closed -$46K – 2413
2021
Q2 		$46K Buy
+1,363
New +$48.2K ﹤0.01% 1487

Other funds holding STOK

ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Point72 Hong Kong's STOK Position: Q4 2022 in Review

Point72 Hong Kong sold out of Stoke Therapeutics (STOK) in Q4 2022, closing a stake of 1,636 shares — an estimated $21K sold.

Point72 Hong Kong first reported a position in STOK in Q2 2021 and held it in 4 quarters. The position peaked at $46K in Q2 2021. 107 funds tracked by Wall St. Rank hold STOK as of Q4 2022.

  • Point72 Hong Kong reported no remaining Stoke Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,636 Stoke Therapeutics shares in Q4 2022, an estimated $21K.
  • Point72 Hong Kong first reported a position in Stoke Therapeutics in Q2 2021 and held it in 4 quarters.
  • Point72 Hong Kong's Stoke Therapeutics position peaked at $46K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.